Cell & Gene Therapy International 2026

Meet ARMI at Cell & Gene Therapy International

ARMI | BioFabUSA is pleased to participate in Cell & Gene Therapy International, taking place September 22–25, 2026, during Biotech Week Boston at the Hynes Convention Center in Boston, Massachusetts.

ARMI’s Chief Regulatory Officer, Richard McFarland, will moderate an expert panel discussing one of the industry’s most important emerging topics—decentralized manufacturing of cell therapies.

Featured Session

Panel Discussion

• Decentralized Manufacturing in Cell Therapy: Overcoming Implementation Challenges and Enhancing Patient-Centric Solutions
• Friday, September 25, 2026
• 9:00 AM

Richard will lead an international panel of industry experts exploring how decentralized manufacturing can improve patient access while maintaining regulatory compliance, manufacturing consistency, and product quality.

Discussion topics include:

• Regulatory oversight for decentralized manufacturing
• Multi-site manufacturing coordination
• Product comparability across manufacturing sites
• Site training and quality management
• Raw material handling
• Digital integration and interoperability
• Strategies for improving patient access to approved cell therapies
• Lessons learned from real-world decentralized manufacturing programs

Panelists include leaders from:

• Aspen Neuroscience
• Massachusetts General Hospital / Harvard Medical School
• Tigen Pharma

ARMI Member Benefit

ARMI | BioFabUSA members receive an exclusive 30% discount on conference registration.

Members interested in attending should contact their ARMI Account Manager (outreach_membership@armiusa.org) to obtain the member discount code and learn more about this exclusive benefit.

If you’re not yet an ARMI member, explore the benefits of membership and how our national network supports organizations advancing the future of bioindustrial manufacturing.

Register